OSCR

What one share of Oscar Health holds

Hospital and Medical Service Plans

Oscar is a leading healthcare technology company built around a full stack technology platform and a relentless focus on member experience. We offer health plans through the ACA serving individuals, families, and employees.

Oscar Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$52.35
Profit$1.91
Capex (buildings and equipment)$0.13
Free cash flow$14.97
Cash and investments$13.49
Debt$1.43
Book value$6.79

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2019$16.94−$9.06$0.90−$6.64—−$32.80
2020$15.81−$14.16$0.48$7.13—−$44.28
2021$10.27−$3.20$0.14−$1.16—$7.75
2022$18.65−$2.85$0.14$1.65—$4.19
2023$26.45−$1.22$0.12−$1.34—$3.63
2024$34.52$0.10$0.10$3.57—$4.22
2025$44.60−$1.69$0.14$4.03—$3.73

Common questions about Oscar Health

How much does one share of Oscar Health earn?

Over the last 12 months, each share of Oscar Health earned $1.91 of profit on $52.35 of sales, keeping about 4¢ of every $1 (profit margin).

Does Oscar Health pay a dividend?

Oscar Health didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Oscar Health’s book value per share?

Oscar Health’s book value is $6.79 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Oscar Health have?

Each share of Oscar Health has $13.49 of cash and investments and $1.43 of debt, as of June 30, 2026.

What is Oscar Health’s free cash flow per share?

$14.97 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Oscar Health bought back shares?

Oscar Health’s share count rose about 811% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.